Pfizer - IIT Delhi Innovation and IP Program

Bringing Healthcare Innovations in India to Life

The Pfizer-IIT Delhi Innovation and IP Program is a collaborative incubation accelerator - co-created by Pfizer and Foundation for Innovation and Technology Transfer (FITT) at the Indian Institute of Technology Delhi (IIT Delhi).

The Program will provide - funding, resources, expertise and infrastructure – to propel India’s healthcare innovations from idea to IP.

Pfizer funding through this program will provide an unencumbered grant of upto Rs. 50 lakhs to each innovator – selected through an appropriately drawn up process.

Patents obtained as a result of the incubation shall belong to the innovators, who will be free to commercialize them as they desire.

Two components of the Pfizer IIT Delhi Innovation & IP Program (PIDIIP)

1. For innovators seeking comprehensive support to translate their healthcare ideas into new business opportunities, the Program provides:
   • Resident incubation at IIT Delhi’s bio-incubator for a period of up to 2 years.
   • Funding of upto INR 50 lakhs for each innovator to take ideas through proof of concept to IP.
   • Mentoring support from IIT Delhi’s faculty and FITT nominated experts.
   • Access to infrastructure, prototyping laboratories and space for setting up an office.
   • IP search and filing services.
   • Guidance from Pfizer’s global experts.
   • Access to venture capitalists and other industry linkages,
2. For innovators who already have a proof of principle /concept and are only looking for IP related support, the program provides:
   • Access to IP counseling services at FITT.
   • Funding support to cover patenting expenses.